These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 21872518)
61. Long-term effects and significant Adverse Drug Reactions (ADRs) associated with the use of Gonadotropin-Releasing Hormone analogs (GnRHa) for central precocious puberty: a brief review of literature. De Sanctis V; Soliman AT; Di Maio S; Soliman N; Elsedfy H Acta Biomed; 2019 Sep; 90(3):345-359. PubMed ID: 31580327 [TBL] [Abstract][Full Text] [Related]
62. Precocious puberty--perspectives on diagnosis and management. Menon PS; Vijayakumar M Indian J Pediatr; 2014 Jan; 81(1):76-83. PubMed ID: 24014184 [TBL] [Abstract][Full Text] [Related]
63. Prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist. Yeshaya A; Kauschansky A; Orvieto R; Varsano I; Nussinovitch M; Ben-Rafael Z Acta Obstet Gynecol Scand; 1998 Mar; 77(3):327-9. PubMed ID: 9539281 [TBL] [Abstract][Full Text] [Related]
64. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment? Léger J; Reynaud R; Czernichow P J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839 [TBL] [Abstract][Full Text] [Related]